Nicholas R Liguori - Lab Translat Oncol & Expt Canc Therapeut, Brown Univ

基本信息

浏览量：5

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 12 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract C088: Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in Pancreatic Cancer

Tej Tummala,Arielle De La Cruz, Ash Uruchurtu,Nicholas R. Liguori,Abbas E. Abbas,Leiqing Zhang,Chistopher G. Azzoli,Lanlan Zhou,Wafik S. El-Deiry

Cancer Researchno. 2_Supplement (2024)

引用0浏览0引用

Synergistic Combinations of Lurbinectedin with ONC212 in Pancreatic Cancer

Tej Tummala, Ashley S. Sevilla Uruchurtu,Nicholas R. Liguori,E. Abbas,Christopher G. Azzoli,Wafik S. El-Deiry

Cancer Researchno. 6_Supplement (2024): 4550-4550

引用0浏览0引用

Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in Pancreatic Cancer

Tej Tummala,Arielle De La Cruz, Ash Uruchurtu,Nicholas R. Liguori,Abbas E. Abbas,Leiqing Zhang,Chistopher G. Azzoli,Lanlan Zhou,Wafik S. El-Deiry

Current Oncology（2023）

引用0浏览0WOS引用

Synergistic Combinations of Lurbinectedin with Irinotecan and ONC212 in Pancreatic Cancer

Tej Tummala,Arielle De La Cruz, Ash Uruchurtu,Nicholas R. Liguori,Abbas E. Abbas,Leiqing Zhang,Christopher G. Azzoli,Lanlan Zhou,Wafik S. El-Deiry

Cancer Researchno. 7_Supplement (2023): 2674-2674

引用0浏览0引用

Abstract B026: Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in Pancreatic Cancer

Tej Tummala,Arielle De La Cruz, Ash Uruchurtu,Nicholas R Liguori,Abbas E Abbas,Leiqing Zhang,Christopher Azzoli,Lanlan Zhou,Wafik S El-Deiry

Molecular Cancer Therapeuticsno. 12_Supplement (2023)

引用0浏览0引用

Molecular Analysis of Small Cell Lung Cancer Provides Insights into Mechanism of Action Underlying the Novel Drug Combination of Lurbinectedin and TIC10/ONC201

Ashley Sanchez Sevilla Uruchurtu,Nicholas Liguori,Leiqing Zhang,Kelsey Huntington,Lanlan Zhou,Young Lee,Abbas E. Abbas,Christopher G. Azzoli,Wafik S. El-Deiry

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Synergistic Activity of Lurbinectidin Plus ONC201 in SCLC is Associated with ATF4, CHOP and Pchk1 Induction

Nicholas R. Liguori, Ashley Fss Uruchurtu,Young Lee,Leiqing Zhang,Abbas,Varun Prabhu,Lanlan Zhou, Christopher J. Azzoli,Wafik S. El-Deiry

CANCER RESEARCH（2022）

引用0浏览0引用

Preclinical Studies with ONC201/TIC10 and Lurbinectedin As a Novel Combination Therapy in Small Cell Lung Cancer (SCLC)

Nicholas R. Liguori,Ashley Sanchez Sevilla Uruchurtu,Leiqing Zhang,Abbas E. Abbas,Young S. Lee,Lanlan Zhou,Christopher G. Azzoli,Wafik S. El-Deiry

PubMed（2022）

引用1浏览0WOS引用

Molecular Targets for Novel Therapeutics in Pediatric Fusion-Positive Non-CNS Solid Tumors

Wen- Chang,Claire Lin,Nicholas Liguori,Joshua N. Honeyman,Bradley DeNardo,Wafik El-Deiry

Frontiers in pharmacology（2022）

引用7浏览0WOS引用

Abdominal Aortitis with Immune Checkpoint Inhibition

Nicholas R Liguori, Michael V Longo, Howard Safran

Journal of Case Reports and Images in Oncologyno. 2 (2021): 1-6

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn